Hepatitis B virus and hepatitis D virus co-infection complicated by autoimmune hepatitis: Two case reports

Table 3 Laboratory tests, cirrhosis status and treatment for case 2

Test item	June 2023	January 2024
Current antiviral medication	Entecavir	Entecavir
Cirrhosis stage	Compensated	Compensated
ALT (U/L)	77.20	47.60
AST (U/L)	60.80	32.90
GGT (U/L)	93.58	86.89
ALP (U/L)	142.50	100.40
Alb (g/L)	40.90	36.40
TBIL (μmol/L)	13.20	7.20
DBIL (μmol/L)	2.90	1.80
IBIL (μmol/L)	10.30	5.40
LDH (U/L)	218.10	214.00
CHE (U/L)	7380	6470.00
TBA (μmol/L)	5.60	21.10
TP (g/L)	78.80	67.90
Glb (g/L)	37.90	31.50
PT (seconds)	13.20	13.50
PTA (%)	83.30	95.0
WBC (109/L)	4.70	6.53
HGB (g/L)	144.00	134.00
PLT (109/L)	143.00	129.00
IgG (g/L)	22.60	14.22
AFP (ng/mL)	10.07	7.40
HBsAg (IU/mL)	7755	9605.00
HBeAg (IU/mL)	0.09	0.12
HBV DNA (IU/mL)	< 20	< 20
Anti-HDV IgM	Positive	Positive
Anti-HDV IgG	Positive	Positive
Liver stiffness (kPa)	21.6	22.7
Fat attenuation (db/m)	294	283
Non-alcoholic fatty liver disease	Present	Present

ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: Gamma-glutamyl transferase; ALP: Alkaline phosphatase; Alb: Albumin; TBIL: Total bilirubin; DBIL: Direct bilirubin; IBIL: Indirect bilirubin; LDH: Lactate dehydrogenase; CHE: Cholinesterase; TBA: Total bile acid; TP: Total protein; Glb: Globulin; PT: Prothrombin time; PTA: Prothrombin time activity; WBC: White blood cell; HGB: Hemoglobin; PLT: Platelet; IgG: Immunoglobulin G; AFP: Alpha-fetoprotein; HBsAg: Hepatitis B surface antigen; HBeAg: Hepatitis B e antigen; HBV: Hepatitis B virus; HDV: Hepatitis D virus; IgM: Immunoglobulin M.